Staff Writer

'American Made' study proves H-1B overhaul is overdue

Strategy execution takes investments to the next level

Third exit option eases pain from sluggish IPO, M&A markets

Cadence Pharmaceuticals Inc.

Another surge

Q4 shows signs of life

Remaking Intel Capital

The head of Intel's venture unit talks about staff reductions and the drive to differentiate his organization from every other venture firm.

Acme Packet Inc.

Trubion Pharmaceuticals Inc.

Granite Global raises fund on solid foundation